Nature Communications (Oct 2018)
Nanodiamond autophagy inhibitor allosterically improves the arsenical-based therapy of solid tumors
Abstract
Arsenic trioxide (ATO) based therapy in solid cancers is limited. Here they repurpose nanodiamonds (NDs) as a safe and potent autophagic inhibitor to improve the efficacy of ATO-based treatment in solid tumors and show the combination therapy to work better in orthotopic liver cancer model.